RSK2/TOP2-IN-1
RSK2/TOP2-IN-1 is a RSK2/TOP2 dual inhibitor. RSK2/TOP2-IN-1 targets key tumor progression enzymes including ribosomal S6 kinase 2 and topoisomerases IIα/IIβ. RSK2/TOP2-IN-1 shows selectivity index > 2 against all squamous cell carcinoma (SCC) cell lines. RSK2/TOP2-IN-1 can induce cell apoptosis, autophagy and ROS production. RSK2/TOP2-IN-1 can be used for the research of cancer, such as squamous cell carcinoma[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; Autophagy; Reactive Oxygen Species (ROS) ; Ribosomal S6 Kinase (RSK) ; Topoisomerase
Related Pathways
Apoptosis; Autophagy; Cell Cycle/DNA Damage; Immunology/Inflammation; MAPK/ERK Pathway; Metabolic Enzyme/Protease; NF-κB
Field of Research
Cancer
Smiles
O=C(C1=CC=CC=C12)C(C(SC3=CC=C(OC)C=C3)C(SC4=CC=C(OC)C=C4)C(C)(C)O5)=C5C2=O
Molecular Formula
C29H26O5S2
Molecular Weight
518.64
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
RSK2; Topo II
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
